27 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
net sales milestone payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing … payments. Joint steering committees have been formed to oversee the clinical studies, regulatory filings, manufacturing, and commercial readiness
8-K
EX-1.1
72v3o lf8v84jwdhso
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
S-3
EX-1.2
ws4zugn05fu
1 Jul 22
Shelf registration
4:13pm
DEF 14A
327j6wjr
28 Apr 22
Definitive proxy
8:36am
424B3
5exz04
12 Nov 21
Prospectus supplement
8:41am
424B3
tr5oe1l e1a79mg
13 Aug 21
Prospectus supplement
5:25pm
S-4/A
EX-10.9
beiiyuc
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.12
inag 4a5jdysk
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
t56m iswy6bed9d6lqj
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.14
qgsv1zad n5bgr
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
w4e iz6cb45h0t
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.15
ocpxsjfxn8d23
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.8
spg h0imd17wk6en
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm